Cite
HARVARD Citation
Rautenberg, T. et al. (2014). Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer. Journal of medical economics. pp. 99-110. [Online].